Pay in 4 interest-free payments of $6.08 Learn more
Ships within 48 hours · Estimated delivery Aug 27 - Sep 1
Like other brain structures, the nucleus accumbens has GLP-1 receptors
Once released from your gut, GLP-1 tells your brain you're full, slows down digestion, and manages insulin release
Theoretical medication interactions to be aware of: Blood-thinning medications (warfarin, aspirin): May enhance effects by influencing platelet function Immunosuppressive drugs : Could oppose desired effects through immune support Antidiabetic medications : May improve insulin sensitivity, potentially requiring dose adjustment Beneficial combinations include: Other antioxidants (vitamin C, E, glutathione): May work synergistically Metformin : One study showed ergothioneine combined with metformin effectively reduced kidney damage in diabetic rats NAD+ precursors: May provide complementary benefits through different pathways The research on ergothioneine and NAD+ suggests these compounds work through distinct but complementary mechanisms
Essential markers include fasting glucose, HbA1c, lipid panel, liver and kidney function, and body composition metrics (DEXA or bioimpedance)
This data indicates that Tbeta4 treatment improved functional recovery after EAE, possibly by reducing inflammatory infiltrates and stimulating oligodendrogenesis
